Dr. Ismat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 US-202/206
Bridgewater, NJ 08807Phone+1 732-487-7288
Summary
- Expert in preclinical and clinical pharmaceutical research.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Cardiology, 1999 - 2002
Baylor College of MedicineResidency, Internal Medicine/Pediatrics, 1995 - 1999
Albany Medical CollegeClass of 1995
Certifications & Licensure
PA State Medical License 1999 - 2022
Publications & Presentations
PubMed
- 6 citationsSafety, Tolerability, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder for Pulmonary Hypertension: A Phase 1, Randomized, Double-Blind, Single- and Mult...Fraz A Ismat, Helen H Usansky, Raul Villa, Jun Zou, Ariel Teper
Advances in Therapy. 2022-11-01 - 69 citationsPAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation.Simon Wilson, Fraz A. Ismat, Zhaoqing Wang, Michael Cerra, Hafid Narayan
Arteriosclerosis, Thrombosis, and Vascular Biology. 2017-12-21 - 7 citationsLong-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium.Jonathan P. Piccini, Richard Clark, Peter R. Kowey, Suneet Mittal, Preston Dunnmon
American Heart Journal. 2017-05-01
Grant Support
- Neurofibromin, RAS &Nfat In Cardiovascular DevelopmentNational Heart, Lung, And Blood Institute2005–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
